The purpose of this work was to study the chemical stability of the new antitumoral β-lapachone (βLAP) to determine the degradation pathway/s of the molecule and the degradation kinetics in addition to identifying several degradation products.
Method Samples of βLAP in solution were stored under conditions of darkness and illumination at 40°C at which the pseudo-first order rate constants for the βLAP degradation were determined. Furthermore, drug degraded solutions were concentrated and purified using Sephadex LH-20 and preparative thin-layer chromatography and degradation products were identified by nuclear magnetic resonance spectroscopy.
The results revealed that βLAP shows two different degradation routes: hydrolysis in the dark and photolysis under the light. The βLAP exposure to light accelerated the drug degradation about 140 fold, compared with the samples stored in the absence of light. The hydrolysis produced hydroxylapachol as the main degradation product. The photolysis yielded phthalic acid, 6-hydroxy-3methylene-3H-isobenzofuran-1-one and a benzomacrolactone together with a complex mixture of other phthalate-derivatives such as 2-(2-carboxy-acetyl)-benzoic acid.
This study provides useful information for the development of βLAP dosage forms, their storage, manipulation and quality control.
本研究旨在研究新型抗肿瘤药物β-拉帕霉素(βLAP)的化学稳定性,确定分子的降解途径和降解动力学,并鉴定多种降解产物。
方法:βLAP溶液样品在40°C的黑暗和照明条件下储存,测定βLAP降解的伪一阶速率常数。此外,使用Sephadex LH-20和制备性薄层色谱对药物降解溶液进行浓缩和纯化,并使用核磁共振光谱鉴定降解产物。
结果显示,βLAP有两种不同的降解途径:在黑暗中水解,在光照下光解。与不受光照的样品相比,βLAP暴露于光线下加速了药物降解约140倍。水解产生羟基拉帕醌作为主要降解产物。光解产生邻苯二甲酸、6-羟基-3-亚甲基-3H-异苯并呋喃-1-酮和苯并马克酸内酯以及其他邻苯二甲酸衍生物的复杂混合物,如2-(2-羧乙酰基)苯甲酸。
本研究为βLAP剂型的开发、储存、操作和质量控制提供了有用的信息。